https://connecticuthealthdigest.com/article/909026761-autonomix-medical-announces-abstract-acceptance-at-digestive-disease-week-2026-showcasing-long-term-data-in-pancreatic-cancer-pain-mitigation Connecticut Health Digest en PressRelease 2026-04-29T12:45:00+00:00 Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation https://ml.globenewswire.com/media/8b0ba1bc-43b1-4445-b895-712da30f7df8/small/logo-png.png https://connecticuthealthdigest.com/article/909026785-renovorx-to-host-first-quarter-2026-financial-results-and-business-highlights-conference-call-on-may-14th-at-4-30-pm-et Connecticut Health Digest en PressRelease 2026-04-29T12:30:00+00:00 RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://connecticuthealthdigest.com/article/909026835-imviva-biotech-to-present-clinical-data-from-ongoing-phase-1-2-study-of-cta313-at-the-american-society-of-gene-cell-therapy-s-annual-meeting Connecticut Health Digest en PressRelease 2026-04-29T12:30:00+00:00 Imviva Biotech to Present Clinical Data from Ongoing Phase 1/2 Study of CTA313 at the American Society of Gene & Cell Therapy's Annual Meeting https://ml.globenewswire.com/media/ZTM4OTJmYWUtMjBkNy00MTliLWE4YWUtZDdkYTE3ZWY5ZTlmLTEzMTkxMjUtMjAyNi0wNC0yOS1lbg==/tiny/Imviva-US-Holdings-LLC.png https://connecticuthealthdigest.com/article/909026866-inaugural-laudio-ashhra-report-reveals-how-hr-leaders-can-strengthen-workforce-stability-through-frontline-leadership Connecticut Health Digest en PressRelease 2026-04-29T12:30:00+00:00 Inaugural Laudio-ASHHRA Report Reveals How HR Leaders Can Strengthen Workforce Stability Through Frontline Leadership https://ml.globenewswire.com/media/M2FhNjFjMzEtMWMzOS00NTZjLTkwYTUtNTU4MzhjYmQ2YTcwLTEyMDA5MjYtMjAyNi0wNC0yOS1lbg==/tiny/Ascend-Learning-Inc-.png https://connecticuthealthdigest.com/article/909026939-nuwellis-highlights-case-study-featuring-precision-ultrafiltration-therapy-in-pediatric-cardiorenal-care-at-ishlt-2026-annual-meeting Connecticut Health Digest en PressRelease 2026-04-29T12:30:00+00:00 Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting https://ml.globenewswire.com/media/92c460b4-3e5c-4a6f-a33c-636a1520d076/small/nuwellis-logo-1-png.png https://connecticuthealthdigest.com/article/909026942-tomi-environmental-solutions-targets-70-billion-u-s-drone-and-defense-budget-with-autonomous-steramist-ihp-decontamination Connecticut Health Digest en PressRelease 2026-04-29T12:30:00+00:00 TOMI Environmental Solutions Targets $70 Billion U.S. Drone and Defense Budget with Autonomous SteraMist iHP Decontamination https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://connecticuthealthdigest.com/article/909026906-laguna-announces-fda-clearance-of-ind-application-for-lgna-100-a-novel-t-cell-activator-for-high-risk-pediatric-leukemias Connecticut Health Digest en PressRelease 2026-04-29T12:29:00+00:00 Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias https://ml.globenewswire.com/media/14da867a-1402-4d3d-b473-d3267f862b39/medium/mechanism-of-action-lgna-100-activated-t-cells-in-acute-mye.png https://connecticuthealthdigest.com/article/909020061-biomerica-s-infoods-ibs-data-accepted-for-presentation-at-digestive-disease-week-2026 Connecticut Health Digest en PressRelease 2026-04-29T12:19:00+00:00 Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://connecticuthealthdigest.com/article/909019727-candel-therapeutics-announces-commercialization-agreement-with-eversana-to-support-potential-u-s-launch-of-aglatimagene-besadenovec-in-localized Connecticut Health Digest en PressRelease 2026-04-29T12:05:00+00:00 Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://connecticuthealthdigest.com/article/909019979-sangamo-therapeutics-announces-transition-to-trading-on-otcqb-venture-market Connecticut Health Digest en PressRelease 2026-04-29T12:05:00+00:00 Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market https://ml.globenewswire.com/media/e3084490-aff3-4c15-8036-d94123563fd0/small/sangamo-logotm-11-11zon-png.png https://connecticuthealthdigest.com/article/909019585-cmr-surgical-submits-510-k-application-to-u-s-fda-to-expand-versius-plus-into-gynecology Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™ into Gynecology https://ml-eu.globenewswire.com/media/7001badd-03d7-4277-b46a-b06118c423cd/small/cmrsurgical-logo-rgb-hi-res-jpg.jpg https://connecticuthealthdigest.com/article/909019623-taysha-gene-therapies-to-release-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-may-6 Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://connecticuthealthdigest.com/article/909019625-electrocore-to-announce-first-quarter-march-31-2026-financial-results-on-wednesday-may-6-2026 Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026 https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://connecticuthealthdigest.com/article/909019635-rein-therapeutics-provides-clinical-trial-update-for-phase-2-renew-study-of-lti-03-in-idiopathic-pulmonary-fibrosis Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis https://ml.globenewswire.com/media/7012d0d8-d19b-4f82-be65-c10f3701019b/small/logo-jpg.jpg https://connecticuthealthdigest.com/article/909019648-picard-medical-syncardia-featured-in-interview-series-with-the-mullings-group Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Picard Medical / SynCardia Featured in Interview Series with The Mullings Group https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://connecticuthealthdigest.com/article/909019660-brainsway-to-report-first-quarter-2026-financial-results-on-may-13-2026 Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg https://connecticuthealthdigest.com/article/909019666-urogen-pharma-to-report-first-quarter-2026-financial-results-on-wednesday-may-6th-2026 Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026 https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png https://connecticuthealthdigest.com/article/909019670-oryzon-to-participate-in-upcoming-events-in-may-and-june Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 ORYZON to Participate in Upcoming Events in May and June https://ml.globenewswire.com/media/56e13ce4-e7d9-45ee-85e9-26feec9b7c6f/small/logo-png.png https://connecticuthealthdigest.com/article/909019680-dlh-to-announce-fiscal-2026-second-quarter-financial-results Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 DLH to Announce Fiscal 2026 Second Quarter Financial Results https://ml.globenewswire.com/media/4efe5f34-0462-4275-ac88-2c8a07c2a9b0/small/dlh-logo-jpg.jpg https://connecticuthealthdigest.com/article/909019773-ultragenyx-to-host-conference-call-for-first-quarter-2026-financial-results-and-corporate-update Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://connecticuthealthdigest.com/article/909019895-inspire-medical-systems-inc-to-present-at-the-bofa-securities-2026-healthcare-conference Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/194e83a5-3f7e-4805-88ce-da2e0ab594df/small/inspire-primary-logo-rgb-daylight-002-png.png https://connecticuthealthdigest.com/article/909019958-ontario-building-code-review-points-to-a-clear-win-for-families-and-future-homeowners-prevent-lung-cancer-cases-by-keeping-radon-mitigation-measures Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Ontario Building Code Review Points to a Clear Win for Families and Future Homeowners: Prevent Lung Cancer Cases by Keeping Radon Mitigation Measures in Place https://ml.globenewswire.com/media/58a138ed-9f59-4520-98a9-1e68ebed4f05/small/lhf-primarylogo-rgb-150dpi-002-orig-png.png https://connecticuthealthdigest.com/article/909019967-calidi-biotherapeutics-announces-strategic-partnership-with-transferai-to-drive-efficiencies-in-the-ind-submission-process-for-cld-401-using-agentic Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://connecticuthealthdigest.com/article/909019973-beacon-therapeutics-annouces-presentations-at-the-arvo-2026-annual-meeting Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting https://ml.globenewswire.com/media/020367be-8998-4af7-93ce-7c0c06f88bcd/small/beacon-logo-jpg.jpg https://connecticuthealthdigest.com/article/909020022-tempest-to-advance-dual-targeting-car-t-platform-with-clinical-update-at-isct-2026-annual-meeting Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://connecticuthealthdigest.com/article/909020117-cortec-s-brain-interchange-bci-system-enables-stroke-patient-to-control-computer-with-his-mind Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind https://ml.globenewswire.com/media/b24bcd60-c029-415f-bcfd-277fade5e278/small/cortec-logo-tm-sub-rgb-transp-png.png https://connecticuthealthdigest.com/article/909020132-tacalyx-secures-11-million-to-advance-lead-taca-targeting-adc-programme-toward-the-clinic Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic https://ml.globenewswire.com/media/7a78b3c0-b303-498d-abc4-fb965e97c7ec/small/2024-tacalyx-logo-442x134-png.png https://connecticuthealthdigest.com/article/909020134-gh-research-announces-pricing-of-117-5-million-underwritten-offering Connecticut Health Digest en PressRelease 2026-04-29T12:00:00+00:00 GH Research Announces Pricing of $117.5 Million Underwritten Offering https://ml.globenewswire.com/media/a1baa9e5-3408-4f8f-b4aa-7c4204e0971b/small/full-colour-png.png https://connecticuthealthdigest.com/article/909012353-emergent-biosolutions-secures-long-term-strategic-manufacturing-contract-with-sab-biotherapeutics-to-advance-type-1-diabetes-candidate-sab-142 Connecticut Health Digest en PressRelease 2026-04-29T11:35:00+00:00 Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142 https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://connecticuthealthdigest.com/article/909012305-cronos-group-inc-to-hold-virtual-2026-annual-meeting-of-shareholders Connecticut Health Digest en PressRelease 2026-04-29T11:30:00+00:00 Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://connecticuthealthdigest.com/article/909012320-anika-reports-first-quarter-2026-financial-results Connecticut Health Digest en PressRelease 2026-04-29T11:05:00+00:00 Anika Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/342e50d9-f0e4-4e79-b568-840299c2045d/small/anika-new-logo-blue-1200x628-png.png https://connecticuthealthdigest.com/article/909012340-corvel-corporation-launches-corvel-connected-an-ai-powered-claims-intelligence-layer-embedded-in-caremc Connecticut Health Digest en PressRelease 2026-04-29T11:05:00+00:00 CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC® https://ml.globenewswire.com/media/dc150059-2d36-47de-9f10-e6f5990ba046/small/corvel-primary-full-color-png.png https://connecticuthealthdigest.com/article/909005174-ocugen-to-host-conference-call-on-tuesday-may-5-at-8-30-a-m-et-to-discuss-business-updates-and-first-quarter-2026-financial-results Connecticut Health Digest en PressRelease 2026-04-29T11:02:00+00:00 Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://connecticuthealthdigest.com/article/909004923-teva-delivers-strong-q1-2026-results-driven-by-innovative-portfolio-growth-and-disciplined-execution Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://connecticuthealthdigest.com/article/909004977-okyo-ceo-and-cso-to-present-and-leadership-team-to-participate-at-upcoming-scientific-conferences-in-may Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg https://connecticuthealthdigest.com/article/909004982-adma-biologics-to-report-first-quarter-2026-financial-results-on-may-6-2026 Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg https://connecticuthealthdigest.com/article/909004990-eyepoint-to-report-first-quarter-2026-financial-results-on-may-6-2026 Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://connecticuthealthdigest.com/article/909005132-vitalhub-announces-q1-2026-conference-call-date Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 VitalHub Announces Q1 2026 Conference Call Date https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://connecticuthealthdigest.com/article/909005179-denovo-announces-issuance-of-u-s-patent-of-novel-genetic-biomarker-ank3-dgm4-for-liafensine-db104 Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104) https://ml.globenewswire.com/media/9e0ac0ad-5d34-4de9-a330-69131a9e6a27/small/denovo-logo-png.png https://connecticuthealthdigest.com/article/909005182-ocular-therapeutix-announces-first-patient-enrolled-in-sol-x-long-term-extension-trial-for-axpaxli-in-wet-amd Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://connecticuthealthdigest.com/article/909005196-tonix-pharmaceuticals-announces-presentation-of-phase-1-data-and-plans-for-an-adaptive-phase-2-field-study-of-tnx-4800-anti-borrelia-ospa-monoclonal Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium… https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://connecticuthealthdigest.com/article/909005293-amarin-reports-2026-first-quarter-financial-results Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 Amarin Reports 2026 First Quarter Financial Results https://ml.globenewswire.com/media/00eeab93-e634-4279-86b3-7973c2a21623/small/amarin-logo-jpeg-jpg.jpg https://connecticuthealthdigest.com/article/909005342-intellia-therapeutics-announces-pricing-of-public-offering-of-common-stock Connecticut Health Digest en PressRelease 2026-04-29T11:00:00+00:00 Intellia Therapeutics Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://connecticuthealthdigest.com/article/909005377-emergent-biosolutions-partners-with-professional-baseball-player-davis-schneider-to-raise-awareness-of-narcan-nasal-spray-among-canadians-and-help Connecticut Health Digest en PressRelease 2026-04-29T10:53:56+00:00 Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives https://ml.globenewswire.com/media/bc0caa11-9c65-478b-a405-4636dbd93f22/medium/emergent-biosolutions-partners-with-professional-baseball-pl.jpg https://connecticuthealthdigest.com/article/909004885-teva-to-acquire-emalex-biosciences-adding-nda-ready-first-in-class-therapy-to-neuroscience-pipeline-and-accelerating-teva-s-pivot-to-growth-strategy Connecticut Health Digest en PressRelease 2026-04-29T10:30:00+00:00 Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://connecticuthealthdigest.com/article/909005156-regeneron-reports-first-quarter-2026-financial-and-operating-results Connecticut Health Digest en PressRelease 2026-04-29T10:30:00+00:00 Regeneron Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://connecticuthealthdigest.com/article/909005189-agios-reports-first-quarter-2026-financial-results-and-provides-business-update Connecticut Health Digest en PressRelease 2026-04-29T10:30:00+00:00 Agios Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://connecticuthealthdigest.com/article/908997446-boehringer-ingelheim-and-eko-health-inc-launch-new-ai-based-solution-that-detects-heart-murmurs-in-dogs Connecticut Health Digest en PressRelease 2026-04-29T10:00:00+00:00 Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://connecticuthealthdigest.com/article/908997588-kestra-medical-technologies-to-present-at-the-bofa-securities-2026-healthcare-conference Connecticut Health Digest en PressRelease 2026-04-29T10:00:00+00:00 Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/88c5ad8d-436a-4085-8905-f884861df934/small/kestra-medical-technologies-1200x628-3-jpg.jpg https://connecticuthealthdigest.com/article/908997602-hutchmed-announces-nda-acceptance-in-china-with-priority-review-status-and-breakthrough-designation-for-sovleplenib-for-the-treatment-of-warm-antibody Connecticut Health Digest en PressRelease 2026-04-29T10:00:00+00:00 HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png https://connecticuthealthdigest.com/article/908960044-enterobiotix-secures-19m-to-initiate-phase-2b-clinical-trial-for-irritable-bowel-syndrome Connecticut Health Digest en PressRelease 2026-04-29T07:00:00+00:00 EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome https://ml-eu.globenewswire.com/media/53e5896a-527b-4c54-aa1d-50c6f83f4332/small/enterobiotix-logo-r-colour-wb-rgb-png.png https://connecticuthealthdigest.com/article/908960036-enlitic-announces-full-integration-with-sectra-expanding-access-for-sectra-customers Connecticut Health Digest en PressRelease 2026-04-29T06:49:10+00:00 Enlitic Announces Full Integration with Sectra, Expanding Access for Sectra Customers https://ml.globenewswire.com/media/ed106073-4458-4f2d-92f4-e960dc457f3c/small/picture1-jpg.jpg https://connecticuthealthdigest.com/article/908960022-angelini-ventures-invests-in-hypervision-surgical-s-17-million-series-a-to-advance-real-time-hyperspectral-imaging-and-improve-clinical-outcomes-in Connecticut Health Digest en PressRelease 2026-04-29T06:30:00+00:00 Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery https://ml-eu.globenewswire.com/media/f440353d-fc61-4c89-9c68-9776e83cb574/medium/tanja-dowe-managing-director-angelini-ventures.jpg https://connecticuthealthdigest.com/article/908950777-purespring-announces-publication-of-notable-study-highlighting-an-under-recognised-genetic-driver-of-adult-onset-fsgs-in-particular-in-us-and-uk Connecticut Health Digest en PressRelease 2026-04-29T06:00:00+00:00 Purespring announces publication of notable study highlighting an under recognised genetic driver of adult-onset FSGS, in particular in US and UK populations https://ml-eu.globenewswire.com/media/7b2b7d1b-8ecc-4a6d-892d-c945b8098d83/small/purespring-logo-png.png https://connecticuthealthdigest.com/article/908941678-phonak-virto-r-infinio-earns-2026-red-dot-award-for-product-design Connecticut Health Digest en PressRelease 2026-04-29T05:05:00+00:00 Phonak Virto ™ R Infinio Earns 2026 Red Dot Award for Product Design https://ml-eu.globenewswire.com/media/3a1eceb4-ac1b-483f-b6d7-397de93e7f8f/medium/phonak-virto-r-infinio-earns-2026-red-dot-award-for-product.jpg https://connecticuthealthdigest.com/article/908941667-addex-gabab-pam-candidate-demonstrates-solid-anti-tussive-activity-in-bleomycin-ipf-related-chronic-cough-model Connecticut Health Digest en PressRelease 2026-04-29T05:00:00+00:00 Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://connecticuthealthdigest.com/article/908932387-dr-bj-rn-zo-ga-o-dimensionamento-de-sistemas-digitais-integrados-ir-definir-o-futuro-da-sa-de Connecticut Health Digest en PressRelease 2026-04-29T04:22:42+00:00 Dr. Björn Zoëga: O Dimensionamento de Sistemas Digitais Integrados Irá Definir o Futuro da Saúde https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908932391-dr-bj-rn-zo-ga-la-ampliaci-n-de-los-sistemas-digitales-integrados-definir-el-futuro-de-la-atenci-n-m-dica Connecticut Health Digest en PressRelease 2026-04-29T04:22:42+00:00 Dr. Björn Zoëga: La ampliación de los sistemas digitales integrados definirá el futuro de la atención médica https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908889529-mesoblast-achieves-patient-recruitment-target-in-pivotal-phase-3-trial-for-chronic-low-back-pain Connecticut Health Digest en PressRelease 2026-04-29T00:53:16+00:00 Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://connecticuthealthdigest.com/article/908889545-innocare-announces-first-patient-dosed-in-phase-iii-trial-of-orelabrutinib-for-sle Connecticut Health Digest en PressRelease 2026-04-29T00:37:04+00:00 InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://connecticuthealthdigest.com/article/908519726-careco-homecare-named-to-elder-care-review-s-top-senior-home-care-services-2026-list Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 CareCo HomeCare Named to Elder Care Review’s “Top Senior Home Care Services 2026” List https://connecticuthealthdigest.com/article/908879991-oruka-therapeutics-announces-pricing-of-upsized-700-million-underwritten-public-offering Connecticut Health Digest en PressRelease 2026-04-28T23:42:56+00:00 Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering https://ml.globenewswire.com/media/3950d2d7-850d-459a-9e42-07c642a841c5/small/oruka-full-color-jpg.jpg https://connecticuthealthdigest.com/article/908869533-arcpoint-announces-resignation-of-board-member Connecticut Health Digest en PressRelease 2026-04-28T23:00:00+00:00 ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER  https://ml.globenewswire.com/media/ed6d0af0-ff83-4628-a141-7cf47ef28d18/small/arcpoint-logo-png.png https://connecticuthealthdigest.com/article/908849360-asap-dental-care-sets-new-benchmark-in-clinical-excellence-with-over-229-000-successful-procedures-performed Connecticut Health Digest en PressRelease 2026-04-28T21:28:00+00:00 ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed https://pressranger.s3.us-west-1.amazonaws.com/3236890/lab-2.jpg https://connecticuthealthdigest.com/article/908849332-careershifters-releases-uk-s-largest-report-on-career-changers-revealing-workplace-health-and-wellbeing-as-primary-driver-of-career-moves Connecticut Health Digest en PressRelease 2026-04-28T21:23:00+00:00 Careershifters Releases UK’s Largest Report on Career Changers, Revealing Workplace Health and Wellbeing as Primary Driver of Career Moves https://ml.globenewswire.com/media/ZWMwNzBhYzMtYzY2Zi00YWRkLWI4MmYtY2E5YmVmZjVhYzk1LTUwMDE2MTc5Mi0yMDI2LTA0LTI4LWVu/tiny/Careershifters.png https://connecticuthealthdigest.com/article/908849435-kfsh-premia-a-los-ganadores-de-innovation-challenge-en-c3-davos-of-healthcare-silicon-valley-summit Connecticut Health Digest en PressRelease 2026-04-28T21:21:42+00:00 KFSH premia a los ganadores de Innovation Challenge en C3 Davos of Healthcare™ Silicon Valley Summit https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908849437-vencedores-do-desafio-da-inova-o-do-pr-mio-kfsh-na-c3-davos-of-healthcare-silicon-valley-summit Connecticut Health Digest en PressRelease 2026-04-28T21:21:42+00:00 Vencedores do Desafio da Inovação do Prêmio KFSH na C3 Davos of Healthcare™ Silicon Valley Summit https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908849407-dr-petros-kotsidis-kfsh-posiciona-la-ia-como-un-modelo-escalable-para-la-innovaci-n-sanitaria-en-el-mundo-real Connecticut Health Digest en PressRelease 2026-04-28T21:15:55+00:00 Dr. Petros Kotsidis: KFSH posiciona la IA como un modelo escalable para la innovación sanitaria en el mundo real https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908849422-dr-petros-kotsidis-kfsh-posiciona-a-ia-como-modelo-escal-vel-para-a-inova-o-na-sa-de-no-mundo-real Connecticut Health Digest en PressRelease 2026-04-28T21:15:55+00:00 Dr. Petros Kotsidis: KFSH Posiciona a IA como Modelo Escalável para a Inovação na Saúde no Mundo Real https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908829632-organogenesis-completes-rolling-submission-of-biologics-license-application-for-renu Connecticut Health Digest en PressRelease 2026-04-28T20:30:00+00:00 Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg https://connecticuthealthdigest.com/article/908829116-pacira-biosciences-files-definitive-proxy-materials-and-mails-letter-to-shareholders Connecticut Health Digest en PressRelease 2026-04-28T20:20:00+00:00 Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://connecticuthealthdigest.com/article/908828833-spectral-ai-schedules-2026-first-quarter-financial-results-and-conference-call Connecticut Health Digest en PressRelease 2026-04-28T20:15:00+00:00 Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://connecticuthealthdigest.com/article/908828993-bioventus-to-report-first-quarter-of-fiscal-year-2026-financial-results-on-may-6-2026 Connecticut Health Digest en PressRelease 2026-04-28T20:15:00+00:00 Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/e10db184-593a-40b5-af02-627c27583108/small/bioventus-logo-png.png https://connecticuthealthdigest.com/article/908828559-nyxoah-to-release-first-quarter-2026-financial-results-on-may-12-2026 Connecticut Health Digest en PressRelease 2026-04-28T20:05:00+00:00 Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://connecticuthealthdigest.com/article/908828610-nyxoah-publiera-ses-r-sultats-financiers-du-premier-trimestre-2026-le-12-mai-2026 Connecticut Health Digest en PressRelease 2026-04-28T20:05:00+00:00 Nyxoah Publiera ses Résultats Financiers du Premier Trimestre 2026 le 12 Mai 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://connecticuthealthdigest.com/article/908828773-myriad-genetics-to-release-first-quarter-2026-financial-results-on-may-5-2026 Connecticut Health Digest en PressRelease 2026-04-28T20:05:00+00:00 Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://connecticuthealthdigest.com/article/908828794-trevi-therapeutics-to-report-first-quarter-2026-financial-results-and-provide-a-corporate-update-on-may-5-2026 Connecticut Health Digest en PressRelease 2026-04-28T20:05:00+00:00 Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026 https://ml.globenewswire.com/media/b97e9d57-6e8e-4570-87da-ea38c273f7c8/small/trevi-logo-jpg.jpg https://connecticuthealthdigest.com/article/908828838-surrozen-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Connecticut Health Digest en PressRelease 2026-04-28T20:05:00+00:00 Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/f8766f36-378a-41ad-9256-3cf0ca847440/small/logoonly-png.png https://connecticuthealthdigest.com/article/908829449-opko-health-reports-first-quarter-2026-business-highlights-and-financial-results Connecticut Health Digest en PressRelease 2026-04-28T20:05:00+00:00 OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://connecticuthealthdigest.com/article/908828573-galapagos-shareholders-adopt-all-resolutions-proposed-by-the-board-of-directors-at-the-annual-and-extraordinary-shareholders-meetings-2026 Connecticut Health Digest en PressRelease 2026-04-28T20:01:00+00:00 Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026 https://ml-eu.globenewswire.com/media/13b034e2-76d4-408b-bffb-c80d85420b03/small/microsoftteams-image-24-png.png https://connecticuthealthdigest.com/article/908828607-aandeelhouders-van-galapagos-keuren-alle-door-de-raad-van-bestuur-voorgestelde-besluiten-goed-op-de-gewone-en-buitengewone-algemene-vergaderingen-van Connecticut Health Digest en PressRelease 2026-04-28T20:01:00+00:00 Aandeelhouders van Galapagos keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de Gewone en Buitengewone Algemene Vergaderingen van 2026 https://ml-eu.globenewswire.com/media/13b034e2-76d4-408b-bffb-c80d85420b03/small/microsoftteams-image-24-png.png https://connecticuthealthdigest.com/article/908829058-cardiff-oncology-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Connecticut Health Digest en PressRelease 2026-04-28T20:01:00+00:00 Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://connecticuthealthdigest.com/article/908829230-design-therapeutics-announces-first-quarter-2026-financial-results-and-recent-business-updates Connecticut Health Digest en PressRelease 2026-04-28T20:01:00+00:00 Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates https://ml.globenewswire.com/media/bbfe687d-5236-42ea-8012-8ab435c6914d/small/designtx-logo-colored-png.png https://connecticuthealthdigest.com/article/908829313-sol-sence-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-12 Connecticut Health Digest en PressRelease 2026-04-28T20:01:00+00:00 Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12 https://ml.globenewswire.com/media/cd3e5e4e-9567-4a86-8f44-900ffeb29d33/small/solesence-fullcolor-300dpi-social-002-1-png.png https://connecticuthealthdigest.com/article/908829344-carlsmed-inc-to-participate-in-upcoming-investor-conferences Connecticut Health Digest en PressRelease 2026-04-28T20:01:00+00:00 Carlsmed, Inc. To Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/ee16eff2-e0d6-40ca-95c5-4dd84bb4cc5f/small/carlsmed-png.png https://connecticuthealthdigest.com/article/908828702-financial-and-strategic-review-annual-general-meeting-and-trading-halt Connecticut Health Digest en PressRelease 2026-04-28T20:00:00+00:00 Financial and Strategic Review, Annual General Meeting, and Trading Halt https://ml-eu.globenewswire.com/media/b5ba012f-32c9-4567-bb3a-c01eb27aa4b0/small/sequana-rgb-300-png.png https://connecticuthealthdigest.com/article/908819400-corza-medical-reaffirms-commitment-to-gut-sutures-amid-changing-market-landscape Connecticut Health Digest en PressRelease 2026-04-28T19:25:27+00:00 Corza Medical Reaffirms Commitment to Gut Sutures Amid Changing Market Landscape https://ml.globenewswire.com/media/7fd01e9c-43bf-4bb9-acbc-96ddee4e78c2/small/griz-corzamedical-full-logo-color-1-100-1-jpg.jpg https://connecticuthealthdigest.com/article/908801643-ernest-and-evelyn-rady-commit-75-million-to-scripps-health Connecticut Health Digest en PressRelease 2026-04-28T18:30:00+00:00 Ernest and Evelyn Rady Commit $75 Million to Scripps Health https://ml.globenewswire.com/media/MzVlYmUzMjEtZTgzZi00MjU5LWI4MmYtMzcwYjVhZWVkZWI5LTExMDA0OTEtMjAyNi0wNC0yOC1lbg==/tiny/Scripps-Health.png https://connecticuthealthdigest.com/article/908792850-fda-announces-major-steps-to-implement-real-time-clinical-trials Connecticut Health Digest en PressRelease 2026-04-28T17:49:00+00:00 FDA Announces Major Steps to Implement Real-Time Clinical Trials https://ml.globenewswire.com/media/NDAwZDBhOGMtOTliNS00NWZjLWEyNmMtNGZiOGU5MjJjODMxLTUwMDE1NDE1NC0yMDI2LTA0LTI4LWVu/tiny/FDA.png https://connecticuthealthdigest.com/article/908776499-correction-quoin-pharmaceuticals-provides-clinical-and-regulatory-update-for-qrx009-topical-rapamycin-development-programs Connecticut Health Digest en PressRelease 2026-04-28T16:02:48+00:00 CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs https://ml.globenewswire.com/media/7002de7e-dd04-45a5-a382-625d5317dbfd/small/quoin-colored-logo-png-png.png https://connecticuthealthdigest.com/article/908776256-truveta-unveils-truveta-intelligence-delivering-real-time-insights-from-real-world-data Connecticut Health Digest en PressRelease 2026-04-28T16:00:00+00:00 Truveta unveils Truveta Intelligence, delivering real-time insights from real-world data https://ml.globenewswire.com/media/MmU2NDU0ZDAtYTFjMC00OWRmLWIzNzUtZDI3MDZkNDVmY2NjLTEyNzUzNzQtMjAyNi0wNC0yOC1lbg==/tiny/Truveta.png https://connecticuthealthdigest.com/article/908761426-axe-compute-to-present-at-the-market-movers-investor-summit-and-the-d-boral-capital-2026-global-conference Connecticut Health Digest en PressRelease 2026-04-28T15:05:43+00:00 Axe Compute to Present at the Market Movers Investor Summit and the D. Boral Capital 2026 Global Conference https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://connecticuthealthdigest.com/article/908761329-agc-2026 Connecticut Health Digest en PressRelease 2026-04-28T15:00:08+00:00 AGCバイオロジクス、2026年「規制・品質コンプライアンスにおけるリーダーシップに対するフィアース・アウトソーシング・アワード」を受賞 https://ml.globenewswire.com/media/YmYyYzA1ZDItYzVlOS00N2FhLWFmOGQtZjBmOGI4ZjM5Njc5LTEzMTU5MjMtMjAyNi0wNC0yOC1qYQ==/tiny/AGC-Biologics-Inc-.png https://connecticuthealthdigest.com/article/908761338-agc-biologics-memenangi-fierce-outsourcing-award-2026-untuk-kepimpinan-dalam-pematuhan-regulasi-dan-kualiti Connecticut Health Digest en PressRelease 2026-04-28T15:00:08+00:00 AGC Biologics Memenangi Fierce Outsourcing Award 2026 untuk Kepimpinan dalam Pematuhan Regulasi dan Kualiti https://ml.globenewswire.com/media/YmYyYzA1ZDItYzVlOS00N2FhLWFmOGQtZjBmOGI4ZjM5Njc5LTEzMTU5MjMtMjAyNi0wNC0yOC1tcw==/tiny/AGC-Biologics-Inc-.png https://connecticuthealthdigest.com/article/908761340-agc-biologics-2026-fierce-outsourcing Connecticut Health Digest en PressRelease 2026-04-28T15:00:08+00:00 AGC Biologics 榮獲 2026 年 Fierce Outsourcing 卓越監管與品質合規領導力大獎 https://ml.globenewswire.com/media/YmYyYzA1ZDItYzVlOS00N2FhLWFmOGQtZjBmOGI4ZjM5Njc5LTEzMTU5MjMtMjAyNi0wNC0yOC16aC1IYW50/tiny/AGC-Biologics-Inc-.png https://connecticuthealthdigest.com/article/908761396-agc-biologics-2026-fierce-outsourcing-awards Connecticut Health Digest en PressRelease 2026-04-28T15:00:08+00:00 AGC Biologics, 2026년 Fierce Outsourcing Awards ‘규제·품질 준수 리더십’ 부문 수상 https://ml.globenewswire.com/media/YmYyYzA1ZDItYzVlOS00N2FhLWFmOGQtZjBmOGI4ZjM5Njc5LTEzMTU5MjMtMjAyNi0wNC0yOC1rbw==/tiny/AGC-Biologics-Inc-.png https://connecticuthealthdigest.com/article/908761408-agc-biologics-2026-fierce-outsourcing-awards Connecticut Health Digest en PressRelease 2026-04-28T15:00:08+00:00 AGC Biologics 荣获 2026 年 Fierce Outsourcing Awards 之法规与质量合规领导力奖 https://ml.globenewswire.com/media/YmYyYzA1ZDItYzVlOS00N2FhLWFmOGQtZjBmOGI4ZjM5Njc5LTEzMTU5MjMtMjAyNi0wNC0yOC16aC1IYW5z/tiny/AGC-Biologics-Inc-.png https://connecticuthealthdigest.com/article/908754065-nbpure-launches-exclusive-mago7-60-count-at-walmart-expanding-access-to-its-best-selling-gut-cleanse Connecticut Health Digest en PressRelease 2026-04-28T14:32:00+00:00 NBPure Launches Exclusive MagO7 60-Count at Walmart, Expanding Access to Its Best-Selling Gut Cleanse https://ml.globenewswire.com/media/55a96f57-fe05-4240-987f-0b7995245537/small/nbpure.png https://connecticuthealthdigest.com/article/908746437-kaleidoscopeai-launches-kal-the-first-ai-growth-system-built-for-orthodontists-at-the-2026-aao-annual-session Connecticut Health Digest en PressRelease 2026-04-28T14:07:00+00:00 KaleidoscopeAI Launches KAL, the First AI Growth System Built for Orthodontists, at the 2026 AAO Annual Session https://pressranger.s3.us-west-1.amazonaws.com/3235522/KaleidoscopeAI---Mary-Kay-Miller-Headshot-KAL-Press-Release2.png https://connecticuthealthdigest.com/article/908746621-bioadaptives-introduces-myndsystem-an-integrated-neuro-performance-repair-system-for-day-and-night Connecticut Health Digest en PressRelease 2026-04-28T14:00:00+00:00 BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night https://ml.globenewswire.com/media/ad289631-6a2e-4b27-bc43-6b7ac688a537/small/bioadaptives-logo-jpg.jpg https://connecticuthealthdigest.com/article/908739774-nexalin-announces-peer-reviewed-publication-with-neuroimaging-data-in-psychotherapy-and-psychosomatics-highlighting-brain-network-effects-and Connecticut Health Digest en PressRelease 2026-04-28T13:15:00+00:00 Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://connecticuthealthdigest.com/article/908739664-minimed-annonce-l-homologation-par-sant-canada-du-capteur-simplera-sync-et-l-indication-pour-le-diab-te-de-type-2-avec-le-syst-me-minimed-780g Connecticut Health Digest en PressRelease 2026-04-28T13:05:00+00:00 MiniMed annonce l’homologation par Santé Canada du capteur Simplera Sync🅪 et l’indication pour le diabète de type 2 avec le système MiniMed🅪 780G https://ml.globenewswire.com/media/4a7a64b3-5dda-4bfa-a366-4f77b5b8fede/medium/minimed-780g.png https://connecticuthealthdigest.com/article/908739673-minimed-announces-health-canada-license-for-simplera-sync-sensor-type-2-diabetes-indication-with-minimed-780g-system Connecticut Health Digest en PressRelease 2026-04-28T13:05:00+00:00 MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System https://ml.globenewswire.com/media/4a7a64b3-5dda-4bfa-a366-4f77b5b8fede/medium/minimed-780g.png https://connecticuthealthdigest.com/article/908734004-a-call-to-action-to-help-fight-kidney-failure-in-at-risk-communities-american-kidney-fund-urges-people-to-be-apol1-aware Connecticut Health Digest en PressRelease 2026-04-28T13:02:01+00:00 A Call to Action to Help Fight Kidney Failure in At-Risk Communities: American Kidney Fund Urges People to be APOL1 Aware https://ml.globenewswire.com/media/Y2Q4ODQyOWEtMTQxOS00OTBmLThiZDQtYmZhY2IzMmY5YWIxLTExMDkwNTItMjAyNi0wNC0yOC1lbg==/tiny/American-Kidney-Fund.png https://connecticuthealthdigest.com/article/908733335-creative-medical-technology-holdings-inc-reports-breakthrough-93-response-rate-in-ultrasome-knee-osteoarthritis-program-expanding-celz-201 Connecticut Health Digest en PressRelease 2026-04-28T13:01:00+00:00 Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies https://ml.globenewswire.com/media/3637f1b5-adfe-4a2c-8fbe-c3cd34cdd7b1/small/celz-logo-2024-png.png https://connecticuthealthdigest.com/article/908733316-aeroflow-health-applauds-georgia-medicaid-s-new-telehealth-lactation-coverage Connecticut Health Digest en PressRelease 2026-04-28T13:00:00+00:00 Aeroflow Health Applauds Georgia Medicaid’s New Telehealth Lactation Coverage https://ml.globenewswire.com/media/f0030ee9-d8c8-4321-a610-4bb1ed358418/small/aeroflow-health-png.png https://connecticuthealthdigest.com/article/908733320-myfitnesspal-launches-comprehensive-glp-1-support-helping-users-stay-consistent-and-build-habits-alongside-medication-to-maximize-their-experience Connecticut Health Digest en PressRelease 2026-04-28T13:00:00+00:00 MyFitnessPal Launches Comprehensive GLP-1 Support, Helping Users Stay Consistent and Build Habits Alongside Medication to Maximize Their Experience https://ml.globenewswire.com/media/4602bc8c-d426-46dc-b679-345bdf7c5fa7/small/mfp-logo-rt-brand-blue-4-png.png https://connecticuthealthdigest.com/article/908733405-muscular-dystrophy-association-marks-als-awareness-month-throughout-may-with-breakthrough-research-powerful-stories-and-nationwide-call-to-action-to Connecticut Health Digest en PressRelease 2026-04-28T13:00:00+00:00 Muscular Dystrophy Association Marks ALS Awareness Month throughout May with Breakthrough Research, Powerful Stories, and Nationwide Call to Action to End ALS https://ml.globenewswire.com/media/ZjNhMDg3NDgtMzcyNy00NGFiLTk1NTYtYmEwNDQ3ZjEyZDY4LTEwOTg0NjYtMjAyNi0wNC0yOC1lbg==/tiny/Muscular-Dystrophy-Association.png https://connecticuthealthdigest.com/article/908733958-alira-health-joins-pfmd-effort-to-advance-patient-centered-evidence-generation Connecticut Health Digest en PressRelease 2026-04-28T13:00:00+00:00 Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation https://ml.globenewswire.com/media/c7422063-e642-4a37-86e3-d85294a19d12/small/alirahealth-jpg.jpg https://connecticuthealthdigest.com/article/908732959-silexion-therapeutics-announces-successful-submission-of-phase-2-3-clinical-trial-application-to-germany-s-bfarm-for-sil204-in-kras-driven-locally Connecticut Health Digest en PressRelease 2026-04-28T12:45:00+00:00 Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer https://ml-eu.globenewswire.com/media/1070dc42-db79-4712-af48-38ffbdf3b140/small/screenshot-2025-05-13-at-15-29-06-png.png https://connecticuthealthdigest.com/article/908733346-ritedose-reaches-1-000-hours-of-purpose Connecticut Health Digest en PressRelease 2026-04-28T12:37:00+00:00 Ritedose Reaches “1,000 Hours of Purpose” https://ml.globenewswire.com/media/fabf2812-dcaa-456e-b281-6a240006203b/medium/celebrating-1-000-hours-of-purpose.jpg https://connecticuthealthdigest.com/article/908733220-polypid-to-present-data-from-shield-ii-phase-3-trial-demonstrating-reduced-severity-of-surgical-site-infection-at-surgical-infection-society-2026 Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting https://ml.globenewswire.com/media/43a11cdb-f86b-4d84-bfb0-1870a0a2cb4e/medium/graph-showing-number-of-patients-with-asepsis-score-20-itt-c.png https://connecticuthealthdigest.com/article/908733318-prodeon-medical-highlights-the-urocross-expander-system-clinical-results-at-the-american-urological-association-aua-2026-annual-meeting Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 Prodeon Medical Highlights the Urocross Expander System Clinical Results at the American Urological Association (AUA) 2026 Annual Meeting https://ml.globenewswire.com/media/a8007909-a9e8-4cd4-b5b6-314e1dd92559/small/prodeon-logo-original-cmyk-png.png https://connecticuthealthdigest.com/article/908733338-nuwellis-announces-receipt-of-a-notice-of-allowance-from-the-u-s-patent-and-trademark-office-for-innovative-dual-lumen-midline-catheter-technology Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology https://ml.globenewswire.com/media/92c460b4-3e5c-4a6f-a33c-636a1520d076/small/nuwellis-logo-1-png.png https://connecticuthealthdigest.com/article/908733342-trimedx-2026-industry-report-outlines-how-health-systems-can-turn-ai-potential-into-operational-performance Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 TRIMEDX 2026 industry report outlines how health systems can turn AI potential into operational performance https://ml.globenewswire.com/media/OTMwYWFjNTktOWM3My00ZjE3LWIxOWQtNjI1N2YxOTRiYjBmLTExOTAzNjQtMjAyNi0wNC0yOC1lbg==/tiny/TRIMEDX.png https://connecticuthealthdigest.com/article/908733365-quoin-pharmaceuticals-provides-clinical-and-regulatory-update-for-qrx009-topical-rapamycin-development-programs Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs https://ml.globenewswire.com/media/7002de7e-dd04-45a5-a382-625d5317dbfd/small/quoin-colored-logo-png-png.png https://connecticuthealthdigest.com/article/908733751-enlivex-treasury-update-total-rain-holdings-rise-to-78-819-756-062-tokens-as-of-april-27-2026-representing-an-aggregated-value-of-567-million Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://connecticuthealthdigest.com/article/908733764-tomi-environmental-solutions-to-present-at-wall-street-reporter-s-next-super-stock-livestream-today-april-28-2026-at-1-p-m-et Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 TOMI Environmental Solutions to Present at Wall Street Reporter’s NEXT SUPER STOCK Livestream Today, April 28, 2026, at 1 p.m. ET https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://connecticuthealthdigest.com/article/908733914-jyong-biotech-updates-market-access-strategy-for-innovative-botanical-drugs-establishing-multiple-competitive-advantages-for-new-drug-portfolio Connecticut Health Digest en PressRelease 2026-04-28T12:30:00+00:00 Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio https://ml.globenewswire.com/media/a1e08c1c-37e5-4fa0-bc16-0b603810bf0a/small/logo-png.png https://connecticuthealthdigest.com/article/908726358-ai-disruption-in-advanced-materials-for-extreme-environments-attracts-262-million-in-strategic-investments Connecticut Health Digest en PressRelease 2026-04-28T12:25:11+00:00 AI Disruption in Advanced Materials for Extreme Environments Attracts $262 Million+ in Strategic Investments https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://connecticuthealthdigest.com/article/908725786-artelo-biosciences-announces-strategic-collaboration-with-artificial-intelligence-ai-leader-sciencemachine-highlighting-new-expansion-opportunities Connecticut Health Digest en PressRelease 2026-04-28T12:25:00+00:00 Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development https://ml.globenewswire.com/media/460502d7-b0d3-43d8-a15a-5b2bb963bbbb/small/artelo-jpg.jpg https://connecticuthealthdigest.com/article/908725984-examworks-announces-appointment-of-isabelle-winkles-as-chief-financial-officer-to-support-continued-growth-and-strategic-execution Connecticut Health Digest en PressRelease 2026-04-28T12:15:00+00:00 ExamWorks Announces Appointment of Isabelle Winkles as Chief Financial Officer to Support Continued Growth and Strategic Execution https://ml.globenewswire.com/media/6250c1f8-d95e-4061-91f2-839b79a5d5e9/small/examworks-logo-png.PNG https://connecticuthealthdigest.com/article/908725993-vivosim-platform-predicts-gastrointestinal-toxicity-diarrhea-in-an-ai-model-trained-on-human-intestinal-model-results-without-animal-testing Connecticut Health Digest en PressRelease 2026-04-28T12:05:00+00:00 VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing https://ml.globenewswire.com/media/636bff82-374b-4c96-8194-5345983eb76a/small/vivosim-logo-final-jpg.jpg https://connecticuthealthdigest.com/article/908726134-catalyst-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-11-2026 Connecticut Health Digest en PressRelease 2026-04-28T12:03:00+00:00 Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026 https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg https://connecticuthealthdigest.com/article/908726329-emergent-biosolutions-and-substipharm-biologics-announce-strategic-manufacturing-partnership-to-support-japanese-encephalitis-vaccine-in-the-united Connecticut Health Digest en PressRelease 2026-04-28T12:01:00+00:00 Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://connecticuthealthdigest.com/article/906956667-evexia-diagnostics-and-cancer-check-labs-partner-to-make-early-accurate-cancer-detection-a-reality Connecticut Health Digest en PressRelease 2026-04-28T00:00:00+00:00 Evexia Diagnostics and Cancer Check Labs Partner to Make Early, Accurate Cancer Detection a Reality https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/21113942-evexia-diagnostics-logo-800x231.png https://connecticuthealthdigest.com/article/908725524-daxor-leverages-medaxiom-cv-transforum-spring-26-to-accelerate-commercial-adoption-of-blood-volume-analysis Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis https://ml.globenewswire.com/media/24a98cc3-3860-436b-901b-dadb081c5f68/small/daxor-logo-thumbnail-png.png https://connecticuthealthdigest.com/article/908725634-proxygen-expands-platform-beyond-degradation-to-build-next-generation-induced-proximity-therapeutics Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics https://ml.globenewswire.com/media/d164dd56-601d-4426-bfe6-8add95bf7984/small/proxygen-logo-black-png.png https://connecticuthealthdigest.com/article/908725663-electrocore-to-present-at-the-market-movers-investor-summit-on-may-5-2026 Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 electroCore to Present at the Market Movers Investor Summit on May 5, 2026 https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://connecticuthealthdigest.com/article/908725677-legend-biotech-to-host-investor-conference-call-on-first-quarter-2026-results Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Legend Biotech to Host Investor Conference Call on First Quarter 2026 Results https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://connecticuthealthdigest.com/article/908725714-prf-technologies-announces-fda-clearance-of-ind-application-for-ocuring-k-phase-ii-clinical-trial Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial https://ml.globenewswire.com/media/245f4060-af56-451d-a821-f5ee6fb5d2e5/small/picture1-jpg.jpg https://connecticuthealthdigest.com/article/908725783-juniper-biosciences-announces-strategic-collaboration-with-leading-global-cancer-center-on-f-miso-jbs-003-a-first-in-class-precision-diagnostic Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment https://ml.globenewswire.com/media/6b9460c2-e6b2-4502-acb7-cde8ae434305/small/juniper-logo-png.png https://connecticuthealthdigest.com/article/908725809-flyte-deploys-additional-vision-jets-in-the-northeast-to-capture-surging-summer-demand Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand https://ml.globenewswire.com/media/cb9f10dc-be78-4c7c-a235-81bfdd77f03c/small/catheterlogo-jpg.jpg https://connecticuthealthdigest.com/article/908725874-camp4-therapeutics-preprints-pioneering-study-on-regulatory-rna-profiling-and-gene-upregulation Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://connecticuthealthdigest.com/article/908725949-solid-biosciences-announces-receipt-of-european-commission-orphan-drug-designation-for-sgt-003-for-the-treatment-of-duchenne-muscular-dystrophy Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://connecticuthealthdigest.com/article/908725972-kestrel-therapeutics-announces-first-patient-dosed-in-the-phase-1-clinical-trial-of-kst-6051-a-potential-best-in-class-pan-kras-inhibitor-in Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies https://ml.globenewswire.com/media/984247bf-62b9-44d2-bf52-61115ea6e446/small/kestrel-logo-color-jpg.jpg https://connecticuthealthdigest.com/article/908725975-cabaletta-bio-and-cellares-announce-10-year-commercial-supply-agreement-for-rese-cel Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png https://connecticuthealthdigest.com/article/908726039-nautilus-biotechnology-reports-first-quarter-2026-financial-results Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Nautilus Biotechnology Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/0ba69f20-8571-4745-a3f7-6c595c1b0198/small/nautilus-primary-logo-blue-jpg.jpg https://connecticuthealthdigest.com/article/908726045-biocardia-announces-allowance-of-japanese-patent-on-proprietary-heart3d-fusion-imaging-software-for-procedure-planning-and-realtime-navigation-during Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 BioCardia Announces Allowance of Japanese Patent on Proprietary Heart3D™ Fusion Imaging Software for Procedure Planning and Realtime Navigation During CardiAMP Cell Therapy Procedures https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://connecticuthealthdigest.com/article/908726223-annovis-publishes-phase-2-3-alzheimer-s-trial-results-in-nature-portfolio Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Annovis Publishes Phase 2/3 Alzheimer's Trial Results in Nature Portfolio https://ml.globenewswire.com/media/7ee459df-d33f-4f42-b27c-3bd20487d50c/small/annovis-corp-image-png.png https://connecticuthealthdigest.com/article/908726299-biomolecular-holdings-announces-issuance-of-foundational-patents-for-revolutionary-tetrahedral-antibody-technology Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology https://ml.globenewswire.com/media/6d94d92c-13aa-4688-9b83-ac3ca52e701e/small/logo-jpg-jpg.jpg https://connecticuthealthdigest.com/article/908726334-cynet-launches-new-capabilities-for-cyai-engine-that-improves-itself-over-time Connecticut Health Digest en PressRelease 2026-04-28T12:00:00+00:00 Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time https://ml.globenewswire.com/media/41b0669e-e65b-448b-9a2f-4140d51fa2cd/small/cynet-logo-2c-png.png https://connecticuthealthdigest.com/article/908719666-3-609-31-mn-biometrics-as-a-service-baas-in-healthcare-market-forecasts-to-2034-rapid-digitalization-of-healthcare-facilities-advancements-in Connecticut Health Digest en PressRelease 2026-04-28T11:43:26+00:00 $3,609.31+ MN Biometrics As a Service (BaaS) in Healthcare Market Forecasts to 2034: Rapid Digitalization of Healthcare Facilities, Advancements in Cloud Technology https://ml.globenewswire.com/media/1f4cf0ab-7d76-4136-a6dc-a5545f80f538/small/zion-market-research-jpg.jpg https://connecticuthealthdigest.com/article/908719364-playground-pediatrics-expands-pediatric-access-across-four-states Connecticut Health Digest en PressRelease 2026-04-28T11:35:00+00:00 Playground Pediatrics Expands Pediatric Access Across Four States https://ml.globenewswire.com/media/b0c3f35c-05ef-4733-a542-eddd1931e23a/small/playground-pediatrics-logo-jpg.jpg https://connecticuthealthdigest.com/article/908719083-kiniksa-pharmaceuticals-reports-first-quarter-2026-financial-results-and-recent-portfolio-execution Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution https://ml-eu.globenewswire.com/media/84055882-69ed-48db-be7d-99cc55be5ff3/small/image1-jpg.jpg https://connecticuthealthdigest.com/article/908719137-aveanna-to-participate-at-the-barclays-30th-annual-leveraged-finance-conference Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Aveanna to Participate at the Barclays 30th Annual Leveraged Finance Conference https://ml.globenewswire.com/media/d3896f9e-a6a1-48c1-a8f7-d9ba5d7433d6/small/aveanna-healthcare-500x262-png.png https://connecticuthealthdigest.com/article/908719161-bridgebio-launches-health-education-effort-on-often-overlooked-heart-condition-featuring-attruby-advocates-morgan-freeman-and-sports-business-icon Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://connecticuthealthdigest.com/article/908719177-plus-therapeutics-secures-blue-shield-of-california-coverage-for-cnside-cerebrospinal-fluid-assay-for-metastatic-cns-cancer Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://connecticuthealthdigest.com/article/908719252-harvard-bioscience-schedules-first-quarter-2026-earnings-conference-call-for-may-12-2026-at-8-00-am-et Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET https://ml.globenewswire.com/media/6784a4a6-c259-489c-8b5b-05266f41b06f/small/hbio-logo-png.png https://connecticuthealthdigest.com/article/908719390-wave-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-update Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://connecticuthealthdigest.com/article/908719396-3d-systems-secures-class-iia-eu-mdr-certification-for-nextdent-jetted-denture-solution-enabling-full-european-commercial-launch-two-months-ahead-of Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 3D Systems Secures Class IIa EU MDR Certification for NextDent® Jetted Denture Solution, Enabling Full European Commercial Launch Two Months Ahead of Schedule https://ml.globenewswire.com/media/c1fe14d5-b586-4dca-a30b-fdfd171ae76f/small/3d-jpg.jpg https://connecticuthealthdigest.com/article/908719413-cytokinetics-announces-nine-upcoming-presentations-at-the-european-society-of-cardiology-heart-failure-2026-congress Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://connecticuthealthdigest.com/article/908719425-helus-pharma-partners-with-tara-mind-to-advance-veteran-mental-health Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health  https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://connecticuthealthdigest.com/article/908719486-inflarx-regains-compliance-with-nasdaq-minimum-bid-price-requirement Connecticut Health Digest en PressRelease 2026-04-28T11:30:00+00:00 InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://connecticuthealthdigest.com/article/908719392-avicanna-welcomes-initial-u-s-rescheduling-of-medical-cannabis-provides-scientific-update Connecticut Health Digest en PressRelease 2026-04-28T11:28:00+00:00 Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://connecticuthealthdigest.com/article/908712828-uniqure-to-announce-first-quarter-2026-financial-results Connecticut Health Digest en PressRelease 2026-04-28T11:05:00+00:00 uniQure to Announce First Quarter 2026 Financial Results https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg https://connecticuthealthdigest.com/article/908713019-kraig-biocraft-laboratories-reports-major-progress-converting-record-setting-spider-silk-cocoon-production-into-reeled-silk Connecticut Health Digest en PressRelease 2026-04-28T11:05:00+00:00 Kraig Biocraft Laboratories Reports Major Progress Converting Record-Setting Spider Silk Cocoon Production into Reeled Silk https://ml.globenewswire.com/media/3d9c9375-604e-4a31-a8d7-ebd5e68f2191/medium/kraig-labs-reeled-recombinant-spider-silk.JPG https://connecticuthealthdigest.com/article/908712762-coultreon-biopharma-raises-125-million-in-series-a-financing-to-advance-immunology-pipeline Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline https://ml-eu.globenewswire.com/media/17b98091-8f01-43aa-887f-f8da2bb83f52/small/coultreon-logo-jpg.jpg https://connecticuthealthdigest.com/article/908712764-coave-therapeutics-to-unveil-oneaavtm-universal-capsid-at-asgct-2026-paving-the-way-for-third-generation-gene-therapy-vectors Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Coave Therapeutics to unveil OneAAVTM universal capsid at ASGCT 2026, paving the way for third generation gene therapy vectors https://ml-eu.globenewswire.com/media/b3d8ab3f-5292-4296-9ffa-7db27ba83e82/small/coave-tx-high-res-logo-1-png.png https://connecticuthealthdigest.com/article/908712781-biocryst-to-present-at-upcoming-investor-conferences Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 BioCryst to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://connecticuthealthdigest.com/article/908712836-avalo-therapeutics-purchases-optional-milestone-buyout Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Avalo Therapeutics Purchases Optional Milestone Buyout https://ml.globenewswire.com/media/950a0fc1-6e06-40b5-9adc-6d3d9f2d5e78/small/avalo-final-black-01-jpg.jpg https://connecticuthealthdigest.com/article/908712891-ocular-therapeutix-to-report-first-quarter-2026-financial-results-on-may-5-2026 Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Ocular Therapeutix™ to Report First Quarter 2026 Financial Results on May 5, 2026 https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://connecticuthealthdigest.com/article/908712895-benitec-biopharma-announces-oral-presentation-of-interim-phase-1b-2a-clinical-study-results-for-high-dose-bb-301-and-continued-durable-improvements Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting https://ml.globenewswire.com/media/627c78fb-57b8-41c6-89da-62599af40dd1/small/logo-png.png https://connecticuthealthdigest.com/article/908712908-axogen-inc-reports-first-quarter-2026-financial-results Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Axogen, Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/3e4ffe78-2e9a-4972-915e-28c8477c84c1/small/axogen-logo-jpg.jpg https://connecticuthealthdigest.com/article/908712919-manitoba-harvest-launches-superfood-smoothie-boosters-exclusively-at-sprouts-farmers-market-nationwide Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Manitoba Harvest Launches Superfood Smoothie Boosters, Exclusively at Sprouts Farmers Market Nationwide https://ml.globenewswire.com/media/bc7370ec-c4c2-43fa-bc84-5f92fd4a5f27/medium/manitoba-harvest-radiant-green.jpeg https://connecticuthealthdigest.com/article/908712972-evolveimmune-therapeutics-announces-achievement-of-preclinical-milestone-in-collaboration-with-abbvie Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVie https://ml.globenewswire.com/media/268d24d0-32bb-4386-b652-75f605803e04/small/logo-color-6-21-25-png.png https://connecticuthealthdigest.com/article/908713051-mbiomics-announces-third-closing-of-series-a-reaching-30-million-to-advance-microbiome-therapeutics Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics https://ml.globenewswire.com/media/8c035ff9-fe7b-4b6d-ad71-126bf3ad30fe/small/mbiomics-logo-orange-rgb-png.png https://connecticuthealthdigest.com/article/908713063-climb-bio-inc-announces-110-0-million-private-placement Connecticut Health Digest en PressRelease 2026-04-28T11:00:00+00:00 Climb Bio, Inc. Announces $110.0 Million Private Placement https://ml.globenewswire.com/media/2a42b557-6e44-4818-bfce-2238a05f2c43/small/climb-400x400-002-jpg.jpg https://connecticuthealthdigest.com/article/908706660-burning-rock-publishes-2025-annual-report-on-form-20-f Connecticut Health Digest en PressRelease 2026-04-28T10:45:11+00:00 Burning Rock Publishes 2025 Annual Report on Form 20-F https://ml.globenewswire.com/media/904d8c1b-eae2-4b6f-83ed-3cb8d0ad31f6/small/logo-01-png.png https://connecticuthealthdigest.com/article/908706670-aclaris-therapeutics-announces-positive-full-top-line-first-in-human-results-from-phase-1a-healthy-volunteer-clinical-trial-of-ati-052-a-novel Connecticut Health Digest en PressRelease 2026-04-28T10:30:00+00:00 Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead… https://ml.globenewswire.com/media/6b2f9dba-280e-4444-8055-6f8112b06aa5/medium/ati-052-pk.png https://connecticuthealthdigest.com/article/908700383-radnet-inc-announces-date-of-its-first-quarter-2026-financial-results-conference-call Connecticut Health Digest en PressRelease 2026-04-28T10:00:00+00:00 RadNet, Inc. Announces Date of its First Quarter 2026 Financial Results Conference Call https://ml.globenewswire.com/media/0df5f357-aa64-4998-a83f-f1561aef685d/small/logo-radnet-profile2-jpg.jpg https://connecticuthealthdigest.com/article/908700384-the-ensign-group-schedules-first-quarter-2026-earnings-call-for-friday-may-1-2026 Connecticut Health Digest en PressRelease 2026-04-28T10:00:00+00:00 The Ensign Group Schedules First Quarter 2026 Earnings Call for Friday, May 1, 2026 https://ml.globenewswire.com/media/43cc375c-326e-4962-89ff-3f917599b33f/small/the-ensign-group-inc-logo.jpg https://connecticuthealthdigest.com/article/908700420-aclarion-appoints-daniel-keefe-as-commercial-director-western-u-s-to-drive-continued-adoption-of-nociscan Connecticut Health Digest en PressRelease 2026-04-28T10:00:00+00:00 Aclarion Appoints Daniel Keefe as Commercial Director, Western U.S., to Drive Continued Adoption of Nociscan https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://connecticuthealthdigest.com/article/908700454-anteris-technologies-secures-cms-reimbursement-supporting-u-s-site-activation-for-paradigm-trial Connecticut Health Digest en PressRelease 2026-04-28T10:00:00+00:00 Anteris Technologies Secures CMS Reimbursement Supporting U.S. Site Activation for PARADIGM Trial https://ml.globenewswire.com/media/90a5ae8d-7cf0-4a3d-b38c-f4ad7e3fbf0e/small/anteris-tech-rgb-blue-png.png https://connecticuthealthdigest.com/article/908694466-kfsh-awards-innovation-challenge-winners-at-c3-davos-of-healthcare-silicon-valley-summit Connecticut Health Digest en PressRelease 2026-04-28T09:31:07+00:00 KFSH Awards Innovation Challenge Winners at C3 Davos of Healthcare™ Silicon Valley Summit https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908694460-dr-petros-kotsidis-kfsh-positions-ai-as-a-scalable-model-for-real-world-healthcare-innovation Connecticut Health Digest en PressRelease 2026-04-28T09:17:59+00:00 Dr. Petros Kotsidis: KFSH Positions AI as a Scalable Model for Real-World Healthcare Innovation https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908694452-dr-bj-rn-zo-ga-scaling-integrated-digital-systems-will-define-the-future-of-healthcare Connecticut Health Digest en PressRelease 2026-04-28T09:16:28+00:00 Dr. Björn Zoëga: Scaling Integrated Digital Systems Will Define the Future of Healthcare https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908678515-theolytics-announces-first-patient-dosed-in-the-octopod-ip-trial-a-us-phase-1-trial-with-theo-260-a-novel-oncolytic-immunotherapy-targeting-ovarian Connecticut Health Digest en PressRelease 2026-04-28T08:00:00+00:00 Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer https://ml-eu.globenewswire.com/media/09792f9d-ea04-4e1e-8cc1-4b0415468690/small/theolytics-jpg.jpg https://connecticuthealthdigest.com/article/908678516-reacta-healthcare-announces-expansion-into-asia-pacific-and-appoints-professor-gary-wing-kin-wong-to-advisory-board Connecticut Health Digest en PressRelease 2026-04-28T08:00:00+00:00 Reacta Healthcare Announces Expansion into Asia-Pacific and Appoints Professor Gary Wing-Kin Wong to Advisory Board https://ml-eu.globenewswire.com/media/d6941784-9703-4de8-886d-5555773da144/small/reactahc-logo-002-jpg.jpg https://connecticuthealthdigest.com/article/908666975-castle-rock-hormone-health-announces-national-franchise-launch-with-franchise-sidekick-amid-growing-demand-for-longevity-medicine Connecticut Health Digest en PressRelease 2026-04-28T06:31:53+00:00 Castle Rock Hormone Health Announces National Franchise Launch with Franchise Sidekick Amid Growing Demand for Longevity Medicine https://ml.globenewswire.com/media/5ec3aa2c-1086-45fa-a0d7-44365c41c348/medium/castle-rock-hormone-health-announces-national-franchise-laun.png https://connecticuthealthdigest.com/article/908666916-bioxodes-to-present-final-phase-2a-trial-results-confirming-breakthrough-potential-of-biox-101-for-intracerebral-hemorrhage-in-poster-at-esoc-2026 Connecticut Health Digest en PressRelease 2026-04-28T06:30:00+00:00 Bioxodes to present final Phase 2a trial results confirming breakthrough potential of BIOX-101 for intracerebral hemorrhage in poster at ESOC 2026 https://ml-eu.globenewswire.com/media/11568637-8587-499f-8472-d6009ae7d0ba/small/bioxodes-logo-fond-transparent-png.png https://connecticuthealthdigest.com/article/908661451-boehringer-ingelheim-s-novel-glucagon-glp-1-dual-agonist-survodutide-achieved-significant-weight-loss-of-16-6-delivering-meaningful-metabolic Connecticut Health Digest en PressRelease 2026-04-28T06:00:00+00:00 Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://connecticuthealthdigest.com/article/908661479-zealand-pharma-announces-boehringer-ingelheim-s-novel-glucagon-glp-1-dual-agonist-survodutide-achieved-significant-weight-loss-of-16-6-delivering Connecticut Health Digest en PressRelease 2026-04-28T06:00:00+00:00 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://connecticuthealthdigest.com/article/908661483-scancell-receives-fda-fast-track-designation-for-iscib1-in-advanced-melanoma-and-provides-data-update-from-its-scope-phase-2-study Connecticut Health Digest en PressRelease 2026-04-28T06:00:00+00:00 Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study https://ml.globenewswire.com/media/ba37ae6d-9792-4da8-85c1-e9a72bf0cc1d/small/scancell-png.png https://connecticuthealthdigest.com/article/908647942-santhera-gibt-positive-entscheidung-des-aifa-vorstands-zur-erstattung-von-agamree-vamorolon-in-italien-bekannt Connecticut Health Digest en PressRelease 2026-04-28T05:01:00+00:00 Santhera gibt positive Entscheidung des AIFA-Vorstands zur Erstattung von AGAMREE® (Vamorolon) in Italien bekannt https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://connecticuthealthdigest.com/article/908647946-santhera-announces-positive-aifa-board-decision-on-reimbursement-of-agamree-vamorolone-in-italy Connecticut Health Digest en PressRelease 2026-04-28T05:01:00+00:00 Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://connecticuthealthdigest.com/article/908647980-santhera-pharmaceuticals-jahresergebnisse-f-r-das-am-31-dezember-2025-endende-gesch-ftsjahr Connecticut Health Digest en PressRelease 2026-04-28T05:00:00+00:00 Santhera Pharmaceuticals Jahresergebnisse für das am 31. Dezember 2025 endende Geschäftsjahr https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://connecticuthealthdigest.com/article/908647989-santhera-pharmaceuticals-full-year-results-for-the-year-ended-31-december-2025 Connecticut Health Digest en PressRelease 2026-04-28T05:00:00+00:00 Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025 https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://connecticuthealthdigest.com/article/908640396-core-soft-tissue-therapy-reports-full-booking-capacity-in-first-year-as-referral-growth-supports-south-london-expansion Connecticut Health Digest en PressRelease 2026-04-28T04:15:31+00:00 CORE Soft Tissue Therapy Reports Full Booking Capacity in First Year as Referral Growth Supports South London Expansion https://ml.globenewswire.com/media/a912b611-1763-46de-86d8-45c89f277f29/medium/core-soft-tissue-therapy-reports-full-booking-capacity-in-fi.png https://connecticuthealthdigest.com/article/908625406-rapid-nutrition-plc-announces-fy2025-results-and-2026-strategic-outlook Connecticut Health Digest en PressRelease 2026-04-28T03:00:00+00:00 Rapid Nutrition PLC Announces FY2025 Results and 2026 Strategic Outlook https://ml-eu.globenewswire.com/media/f5152816-94d7-4584-a49f-05ae66a44bf0/small/rapid-jpg.jpg https://connecticuthealthdigest.com/article/908584685-educational-webinar-unlocking-the-potential-of-psma-therapy-a-next-generation-portfolio-approach Connecticut Health Digest en PressRelease 2026-04-27T23:27:05+00:00 Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://connecticuthealthdigest.com/article/908576299-new-peer-reviewed-study-reveals-actionable-immune-microenvironment-target-in-brain-metastasis-medicinova-advances-clinical-translation Connecticut Health Digest en PressRelease 2026-04-27T23:00:00+00:00 New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation https://ml.globenewswire.com/media/b206e905-1d01-44c2-bc62-c2d6a10afd0a/small/medicinova-inc-logo.jpg https://connecticuthealthdigest.com/article/908576394-kfsh-se-une-a-la-conferencia-global-2026-del-instituto-milken-en-beverly-hills-california-como-patrocinador-silver Connecticut Health Digest en PressRelease 2026-04-27T22:55:00+00:00 KFSH se une a la Conferencia Global 2026 del Instituto Milken en Beverly Hills, California, como patrocinador Silver https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908576416-kfsh-participa-da-milken-institute-global-conference-2026-em-beverly-hills-calif-rnia-como-patrocinador-prata Connecticut Health Digest en PressRelease 2026-04-27T22:55:00+00:00 KFSH Participa da Milken Institute Global Conference 2026 em Beverly Hills, Califórnia, como Patrocinador Prata https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://connecticuthealthdigest.com/article/908559413-biomea-fusion-announces-positive-52-week-results-from-phase-2-covalent-112-trial-in-type-1-diabetes-showing-c-peptide-improvement-and-durability Connecticut Health Digest en PressRelease 2026-04-27T21:37:38+00:00 Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment https://ml.globenewswire.com/media/65d84e8f-dc21-4794-a041-80bf6b8ede2c/medium/52-mean-increase-in-c-peptide-from-baseline-at-week-12.jpeg https://connecticuthealthdigest.com/article/908551378-taysha-gene-therapies-to-present-new-preclinical-data-supporting-construct-design-of-tsha-102-for-rett-syndrome-at-the-asgct-2026-annual-meeting Connecticut Health Digest en PressRelease 2026-04-27T21:21:27+00:00 Taysha Gene Therapies to Present New Preclinical Data Supporting Construct Design of TSHA-102 for Rett Syndrome at the ASGCT 2026 Annual Meeting https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://connecticuthealthdigest.com/article/908551374-lexeo-therapeutics-announces-multiple-presentations-at-the-29th-american-society-of-gene-cell-therapy-asgct-annual-meeting Connecticut Health Digest en PressRelease 2026-04-27T21:15:00+00:00 Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting https://ml.globenewswire.com/media/85c275df-e665-426f-a3bc-4a839a0b34d3/small/lexeo-logo-png.png https://connecticuthealthdigest.com/article/908551359-crinetics-pharmaceuticals-announces-the-european-commission-approval-of-palsonify-paltusotine-for-the-treatment-of-acromegaly-in-adults Connecticut Health Digest en PressRelease 2026-04-27T21:13:08+00:00 Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults https://ml.globenewswire.com/media/ff5e7cfa-b9fb-4679-8bf3-6e9d25207b83/small/crinetics-logo-trademark-jpg-1-jpg.jpg https://connecticuthealthdigest.com/article/908551219-elevatebio-to-present-nine-abstracts-showcasing-advancements-across-its-gene-editing-platform-at-the-american-society-of-gene-and-cell-therapy-asgct Connecticut Health Digest en PressRelease 2026-04-27T21:00:00+00:00 ElevateBio to Present Nine Abstracts Showcasing Advancements Across its Gene Editing Platform at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting https://ml.globenewswire.com/media/42238eb2-fd1c-4189-bf14-c7026687de5b/small/elevatebiologo-jpg.jpg https://connecticuthealthdigest.com/article/908551243-arbor-biotechnologies-to-present-expansion-of-cns-editing-platform-capabilities-at-the-american-society-of-gene-and-cell-therapy-asgct-29th-annual Connecticut Health Digest en PressRelease 2026-04-27T21:00:00+00:00 Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting https://ml.globenewswire.com/media/68842426-d5ae-4dd2-800a-89d80ad4b3b7/small/arbor-biotech-logo-web-3-1-jpg.jpg